Read More Pharma Industry News Breakthrough EU approval for Dupixent offers new hope for children with eosinophilic esophagitis The European Medicines Agency (EMA) has granted approval for Dupixent, a therapy developed by Sanofi and Regeneron, to… byPallavi MadhirajuNovember 8, 2024